Alkermes to Host Conference Call to Discuss Second Quarter 2020 Financial Results

Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) will host a conference call on July 29, 2020, at 8:00 a.m. ET to discuss its second quarter 2020 financial results. The call will provide insights into the company's performance and updates on business developments. Investors can access the webcast on Alkermes' website. A replay will be available from 11:00 a.m. ET on the same day through August 5, 2020. Alkermes, based in Dublin, specializes in neuroscience and oncology, focusing on innovative treatments for addiction, schizophrenia, and cancer.

Positive

• Conference call to discuss second quarter financial results indicates transparency and engagement with investors.
• Company has a robust pipeline in neuroscience and oncology, suggesting potential for future growth.

Negative

• None.

DUBLIN, July 22, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Wednesday, July 29, 2020 to discuss the company's second quarter 2020 financial results. Management will also provide an update on the company.

The webcast player and accompanying slides may be accessed on the Investors section of Alkermes' website at www.alkermes.com. The conference call may be accessed by dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 for international callers.

A replay of the conference call will be available from 11:00 a.m. ET (4:00 p.m. BST) on Wednesday, July 29, 2020, through Wednesday, Aug. 5, 2020, and may be accessed by visiting Alkermes' website or by dialing +1 877 660 6853 for U.S. callers and +1 201 612 7415 for international callers. The replay access code is 13707215. 

About Alkermes plc

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes Contact:
Alex Braun
Investor Relations
+1 781 296 8493

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-to-host-conference-call-to-discuss-second-quarter-2020-financial-results-301098230.html

SOURCE Alkermes plc

FAQ

When is Alkermes' second quarter 2020 earnings call?

Alkermes' second quarter 2020 earnings call is scheduled for July 29, 2020, at 8:00 a.m. ET.

How can I access Alkermes' conference call?

You can access the conference call by dialing +1 877 407 2988 for U.S. callers or +1 201 389 0923 for international callers.

What are the topics expected to be discussed in the earnings call?

The call will discuss Alkermes' second quarter 2020 financial results and provide updates on the company's development.

Is there a replay available for the Alkermes earnings call?

Yes, a replay will be available from 11:00 a.m. ET on July 29, 2020, until August 5, 2020.

Where can I find the webcast of Alkermes' conference call?

The webcast can be accessed on the Investors section of Alkermes' website.